Global Sustained Release Injectables Market Research Report 2021

Global Sustained Release Injectables Market Research Report 2021

Table of Contents
1 Sustained Release Injectables Market Overview
1.1 Product Overview and Scope of Sustained Release Injectables
1.2 Sustained Release Injectables Segment by Type
1.2.1 Global Sustained Release Injectables Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Naltrexone
1.2.3 Exenatide
1.2.4 Estradiol
1.2.5 Other
1.3 Sustained Release Injectables Segment by Application
1.3.1 Sustained Release Injectables Sales Comparison by Application: (2021-2027)
1.3.2 Diabetes
1.3.3 Leukemia
1.3.4 Acromegaly
1.3.5 Other
1.4 Global Sustained Release Injectables Market Size Estimates and Forecasts
1.4.1 Global Sustained Release Injectables Revenue 2016-2027
1.4.2 Global Sustained Release Injectables Sales 2016-2027
1.4.3 Sustained Release Injectables Market Size by Region: 2016 Versus 2021 Versus 2027
2 Sustained Release Injectables Market Competition by Manufacturers
2.1 Global Sustained Release Injectables Sales Market Share by Manufacturers (2016-2021)
2.2 Global Sustained Release Injectables Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Sustained Release Injectables Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Sustained Release Injectables Manufacturing Sites, Area Served, Product Type
2.5 Sustained Release Injectables Market Competitive Situation and Trends
2.5.1 Sustained Release Injectables Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Sustained Release Injectables Players Market Share by Revenue
2.5.3 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sustained Release Injectables Retrospective Market Scenario by Region
3.1 Global Sustained Release Injectables Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Sustained Release Injectables Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Sustained Release Injectables Market Facts & Figures by Country
3.3.1 North America Sustained Release Injectables Sales by Country
3.3.2 North America Sustained Release Injectables Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sustained Release Injectables Market Facts & Figures by Country
3.4.1 Europe Sustained Release Injectables Sales by Country
3.4.2 Europe Sustained Release Injectables Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sustained Release Injectables Market Facts & Figures by Region
3.5.1 Asia Pacific Sustained Release Injectables Sales by Region
3.5.2 Asia Pacific Sustained Release Injectables Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sustained Release Injectables Market Facts & Figures by Country
3.6.1 Latin America Sustained Release Injectables Sales by Country
3.6.2 Latin America Sustained Release Injectables Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sustained Release Injectables Market Facts & Figures by Country
3.7.1 Middle East and Africa Sustained Release Injectables Sales by Country
3.7.2 Middle East and Africa Sustained Release Injectables Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Sustained Release Injectables Historic Market Analysis by Type
4.1 Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
4.2 Global Sustained Release Injectables Revenue Market Share by Type (2016-2021)
4.3 Global Sustained Release Injectables Price by Type (2016-2021)
5 Global Sustained Release Injectables Historic Market Analysis by Application
5.1 Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
5.2 Global Sustained Release Injectables Revenue Market Share by Application (2016-2021)
5.3 Global Sustained Release Injectables Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Eli Lilly Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Roche Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Aurobindo
6.6.1 Aurobindo Corporation Information
6.6.2 Aurobindo Description and Business Overview
6.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Aurobindo Product Portfolio
6.6.5 Aurobindo Recent Developments/Updates
6.7 Avadel
6.6.1 Avadel Corporation Information
6.6.2 Avadel Description and Business Overview
6.6.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Avadel Product Portfolio
6.7.5 Avadel Recent Developments/Updates
6.8 Biomarin
6.8.1 Biomarin Corporation Information
6.8.2 Biomarin Description and Business Overview
6.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biomarin Product Portfolio
6.8.5 Biomarin Recent Developments/Updates
6.9 Camurus
6.9.1 Camurus Corporation Information
6.9.2 Camurus Description and Business Overview
6.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Camurus Product Portfolio
6.9.5 Camurus Recent Developments/Updates
6.10 Critical Pharmaceuticals
6.10.1 Critical Pharmaceuticals Corporation Information
6.10.2 Critical Pharmaceuticals Description and Business Overview
6.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Critical Pharmaceuticals Product Portfolio
6.10.5 Critical Pharmaceuticals Recent Developments/Updates
6.11 Alkermes
6.11.1 Alkermes Corporation Information
6.11.2 Alkermes Sustained Release Injectables Description and Business Overview
6.11.3 Alkermes Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Alkermes Product Portfolio
6.11.5 Alkermes Recent Developments/Updates
6.12 Amylin
6.12.1 Amylin Corporation Information
6.12.2 Amylin Sustained Release Injectables Description and Business Overview
6.12.3 Amylin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Amylin Product Portfolio
6.12.5 Amylin Recent Developments/Updates
6.13 Ascendis Pharma
6.13.1 Ascendis Pharma Corporation Information
6.13.2 Ascendis Pharma Sustained Release Injectables Description and Business Overview
6.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Ascendis Pharma Product Portfolio
6.13.5 Ascendis Pharma Recent Developments/Updates
6.14 Taiwan Liposome Company
6.14.1 Taiwan Liposome Company Corporation Information
6.14.2 Taiwan Liposome Company Sustained Release Injectables Description and Business Overview
6.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Taiwan Liposome Company Product Portfolio
6.14.5 Taiwan Liposome Company Recent Developments/Updates
7 Sustained Release Injectables Manufacturing Cost Analysis
7.1 Sustained Release Injectables Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sustained Release Injectables
7.4 Sustained Release Injectables Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sustained Release Injectables Distributors List
8.3 Sustained Release Injectables Customers
9 Sustained Release Injectables Market Dynamics
9.1 Sustained Release Injectables Industry Trends
9.2 Sustained Release Injectables Growth Drivers
9.3 Sustained Release Injectables Market Challenges
9.4 Sustained Release Injectables Market Restraints
10 Global Market Forecast
10.1 Sustained Release Injectables Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sustained Release Injectables by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Sustained Release Injectables by Type (2022-2027)
10.2 Sustained Release Injectables Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sustained Release Injectables by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Sustained Release Injectables by Application (2022-2027)
10.3 Sustained Release Injectables Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sustained Release Injectables by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Sustained Release Injectables by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Sustained Release Injectables Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Sustained Release Injectables Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Sustained Release Injectables Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Sustained Release Injectables Covered in This Study
Table 5. Global Sustained Release Injectables Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Sustained Release Injectables Sales Share by Manufacturers (2016-2021)
Table 7. Global Sustained Release Injectables Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Sustained Release Injectables Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Sustained Release Injectables Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Sustained Release Injectables Manufacturing Sites and Area Served
Table 11. Manufacturers Sustained Release Injectables Product Type
Table 12. Global Sustained Release Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sustained Release Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Sustained Release Injectables Sales by Region (2016-2021) & (K Units)
Table 16. Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
Table 17. Global Sustained Release Injectables Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Sustained Release Injectables Sales by Country (2016-2021) & (K Units)
Table 19. North America Sustained Release Injectables Sales Market Share by Country (2016-2021)
Table 20. North America Sustained Release Injectables Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Sustained Release Injectables Revenue Market Share by Country (2016-2021)
Table 22. Europe Sustained Release Injectables Sales by Country (2016-2021) & (K Units)
Table 23. Europe Sustained Release Injectables Sales Market Share by Country (2016-2021)
Table 24. Europe Sustained Release Injectables Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Sustained Release Injectables Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Sustained Release Injectables Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Sustained Release Injectables Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Sustained Release Injectables Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Sustained Release Injectables Revenue Market Share by Region (2016-2021)
Table 30. Latin America Sustained Release Injectables Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Sustained Release Injectables Sales Market Share by Country (2016-2021)
Table 32. Latin America Sustained Release Injectables Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Sustained Release Injectables Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Sustained Release Injectables Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Sustained Release Injectables Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Sustained Release Injectables Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Sustained Release Injectables Revenue Market Share by Country (2016-2021)
Table 38. Global Sustained Release Injectables Sales (K Units) by Type (2016-2021)
Table 39. Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
Table 40. Global Sustained Release Injectables Revenue (Million US$) by Type (2016-2021)
Table 41. Global Sustained Release Injectables Revenue Share by Type (2016-2021)
Table 42. Global Sustained Release Injectables Price (USD/Unit) by Type (2016-2021)
Table 43. Global Sustained Release Injectables Sales (K Units) by Application (2016-2021)
Table 44. Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
Table 45. Global Sustained Release Injectables Revenue (Million US$) by Application (2016-2021)
Table 46. Global Sustained Release Injectables Revenue Share by Application (2016-2021)
Table 47. Global Sustained Release Injectables Price (USD/Unit) by Application (2016-2021)
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Business Overview
Table 50. AstraZeneca Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. AstraZeneca Sustained Release Injectables Product
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Eli Lilly Corporation Information
Table 54. Eli Lilly Description and Business Overview
Table 55. Eli Lilly Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Eli Lilly Sustained Release Injectables Product
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Sanofi Sustained Release Injectables Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Roche Corporation Information
Table 64. Roche Description and Business Overview
Table 65. Roche Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Roche Sustained Release Injectables Product
Table 67. Roche Recent Developments/Updates
Table 68. Novartis Corporation Information
Table 69. Novartis Description and Business Overview
Table 70. Novartis Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Novartis Sustained Release Injectables Product
Table 72. Novartis Recent Developments/Updates
Table 73. Aurobindo Corporation Information
Table 74. Aurobindo Description and Business Overview
Table 75. Aurobindo Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Aurobindo Sustained Release Injectables Product
Table 77. Aurobindo Recent Developments/Updates
Table 78. Avadel Corporation Information
Table 79. Avadel Description and Business Overview
Table 80. Avadel Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Avadel Sustained Release Injectables Product
Table 82. Avadel Recent Developments/Updates
Table 83. Biomarin Corporation Information
Table 84. Biomarin Description and Business Overview
Table 85. Biomarin Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Biomarin Sustained Release Injectables Product
Table 87. Biomarin Recent Developments/Updates
Table 88. Camurus Corporation Information
Table 89. Camurus Description and Business Overview
Table 90. Camurus Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Camurus Sustained Release Injectables Product
Table 92. Camurus Recent Developments/Updates
Table 93. Critical Pharmaceuticals Corporation Information
Table 94. Critical Pharmaceuticals Description and Business Overview
Table 95. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Critical Pharmaceuticals Sustained Release Injectables Product
Table 97. Critical Pharmaceuticals Recent Developments/Updates
Table 98. Alkermes Corporation Information
Table 99. Alkermes Description and Business Overview
Table 100. Alkermes Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Alkermes Sustained Release Injectables Product
Table 102. Alkermes Recent Developments/Updates
Table 103. Amylin Corporation Information
Table 104. Amylin Description and Business Overview
Table 105. Amylin Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Amylin Sustained Release Injectables Product
Table 107. Amylin Recent Developments/Updates
Table 108. Ascendis Pharma Corporation Information
Table 109. Ascendis Pharma Description and Business Overview
Table 110. Ascendis Pharma Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Ascendis Pharma Sustained Release Injectables Product
Table 112. Ascendis Pharma Recent Developments/Updates
Table 113. Taiwan Liposome Company Corporation Information
Table 114. Taiwan Liposome Company Description and Business Overview
Table 115. Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Taiwan Liposome Company Sustained Release Injectables Product
Table 117. Taiwan Liposome Company Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Sustained Release Injectables Distributors List
Table 121. Sustained Release Injectables Customers List
Table 122. Sustained Release Injectables Market Trends
Table 123. Sustained Release Injectables Growth Drivers
Table 124. Sustained Release Injectables Market Restraints
Table 125. Global Sustained Release Injectables Sales Forecast by Type (2022-2027) & (K Units)
Table 126. Global Sustained Release Injectables Sales Market Share Forecast by Type (2022-2027)
Table 127. Global Sustained Release Injectables Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 128. Global Sustained Release Injectables Revenue Market Share Forecast by Type (2022-2027)
Table 129. Global Sustained Release Injectables Sales Forecast by Application (2022-2027) & (K Units)
Table 130. Global Sustained Release Injectables Sales Market Share Forecast by Application (2022-2027)
Table 131. Global Sustained Release Injectables Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 132. Global Sustained Release Injectables Revenue Market Share Forecast by Application (2022-2027)
Table 133. Global Sustained Release Injectables Sales Forecast by Region (2022-2027) & (K Units)
Table 134. Global Sustained Release Injectables Sales Market Share Forecast by Region (2022-2027)
Table 135. Global Sustained Release Injectables Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 136. Global Sustained Release Injectables Revenue Market Share Forecast by Region (2022-2027)
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sustained Release Injectables
Figure 2. Global Sustained Release Injectables Market Share by Type in 2020 & 2027
Figure 3. Naltrexone Product Picture
Figure 4. Exenatide Product Picture
Figure 5. Estradiol Product Picture
Figure 6. Other Product Picture
Figure 7. Global Sustained Release Injectables Market Share by Application in 2020 & 2027
Figure 8. Diabetes
Figure 9. Leukemia
Figure 10. Acromegaly
Figure 11. Other
Figure 12. Global Sustained Release Injectables Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Sustained Release Injectables Market Size 2016-2027 (US$ Million)
Figure 14. Global Sustained Release Injectables Sales 2016-2027 (K Units)
Figure 15. Global Sustained Release Injectables Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Sustained Release Injectables Sales Share by Manufacturers in 2020
Figure 17. Global Sustained Release Injectables Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Sustained Release Injectables Players: Market Share by Revenue in 2020
Figure 19. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
Figure 21. Global Sustained Release Injectables Sales Market Share by Region in 2020
Figure 22. Global Sustained Release Injectables Revenue Market Share by Region (2016-2021)
Figure 23. Global Sustained Release Injectables Revenue Market Share by Region in 2020
Figure 24. U.S. Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Sustained Release Injectables by Type (2016-2021)
Figure 49. Sales Market Share of Sustained Release Injectables by Application (2016-2021)
Figure 50. Sales Market Share of Sustained Release Injectables by Application in 2020
Figure 51. Revenue Share of Sustained Release Injectables by Application (2016-2021)
Figure 52. Revenue Share of Sustained Release Injectables by Application in 2020
Figure 53. Manufacturing Cost Structure of Sustained Release Injectables
Figure 54. Manufacturing Process Analysis of Sustained Release Injectables
Figure 55. Sustained Release Injectables Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs